Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services in more than 100 countries.
As pioneers in the field of the plasma science, we are one of the largest plasma companies with a growing network of donation centers worldwide. We develop this plasma into essential medicines used to treat rare, chronic and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, we also offer a comprehensive portfolio of solutions designed to enhance safety from donation through transfusion. We continue to advance our legacy of innovation by supplying tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.
Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry.
Grifols leads in changing perceptions about plasma donation. We speak out about the pride we have in our donors and the vital importance of our products for patients and their families. Our legacy and history of commitment to donors and patients motivates our commitment to future innovation and progress in the industry.
With plasma donation centers across the United States, the Grifols network likely has a location that's convenient for you. Each of these centers is managed by one of our three companies: Biomat USA, Inc., PlasmaCare, Inc., or Talecris Plasma Resources, Inc.
